Amerisourcebergen
Health Care |
Pharmaceutical Companies
1300 Morris Dr, Chesterbrook, PA 19087
Recent News About Amerisourcebergen
-
The Illinois Public Risk Fund, an organization which helps Illinois local governments pool their workers' compensation insurance, and its lawyers from Edelson P.C., has won the chance to sidestep the federal courts’ “black hole” as it pursues its own legal claims against the makers and distributors of so-called opioid painkillers.
-
Two unions have added their names to the long and growing list of organizations suing the makers and distributors of opioid painkillers.
-
Organizations providing workers comp insurance and employee health insurance for more than 200 Illinois local governments have joined the mass of lawsuits against drug makers, distributors and others associated with the spread of so-called opioid painkillers.
-
Three more Cook County communities are suing opioid makers and distributors in connection with the opioid epidemic. But unlike dozens of other Chicago-area towns that have already taken similar court action, the three towns are suing separately, rather than together, and have added medical societies as defendants.
-
Another group of Cook County communities have launched a lawsuit, which they want to stay in Cook County rather than federal court, against a number of opioid makers, distributors and doctors, alleging they pushed prescription opioids on the public despite knowing the drugs were dangerously addictive.
-
A Chicago class-action lawyer has filed a 97-page lawsuit in Chicago federal court against 13 drug companies and distributors, on behalf of a woman who alleges the companies promoted opioid use, knowing such painkillers were dangerously addictive, jacking up people's health insurance costs.
-
As class action litigation continues to grow across the U.S. against the pharmaceutical companies that made opioid prescription painkillers, the city of Chicago has also set its sights in court on three companies it blames for distributing the addictive pills here, saying the companies should be made to pay for allegedly not monitoring the flow of the drugs or halting the suspicious activity at pharmacies and elsewhere that allegedly “fueled” the black market for the drugs.
